Blueprint Medicines Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.87 M | $599.14 M | -3.51% | 10.84% |
VANGUARD GROUP INC | 02/11/2025 | 6.77 M | $590.91 M | 1.37% | 10.69% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 5.68 M | $495.33 M | 5.42% | 8.96% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 4.28 M | $373.42 M | 7.99% | 6.76% |
STATE STREET CORP | 02/14/2025 | 2.50 M | $218.07 M | -9.60% | 3.94% |
FMR LLC | 02/13/2025 | 2.25 M | $196.04 M | -50.24% | 3.55% |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 02/10/2025 | 1.94 M | $169.62 M | 16.12% | 3.07% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.49 M | $130.00 M | 0.67% | 2.35% |
MACQUARIE GROUP LTD | 02/14/2025 | 1.26 M | $109.81 M | -0.37% | 1.99% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 1.19 M | $103.36 M | 100.00% | 1.87% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.18 M | $103.24 M | 1.47% | 1.87% |
JPMORGAN CHASE & CO | 02/12/2025 | 1.16 M | $100.79 M | -5.44% | 1.82% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.14 M | $99.26 M | -6.54% | 1.80% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.10 M | $95.67 M | 42.68% | 1.73% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.05 M | $91.28 M | 45.02% | 1.65% |
INVESCO LTD. | 02/13/2025 | 960,437 | $83.77 M | 6.67% | 1.52% |
JANE STREET GROUP, LLC | 02/14/2025 | 950,100 | $82.87 M | 68.64% | 1.50% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 879,932 | $76.75 M | 30.86% | 1.39% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 862,285 | $75.21 M | 147.28% | 1.36% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 839,203 | $73.20 M | 2.96% | 1.32% |
ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 800,628 | $69.83 M | 11.36% | 1.26% |
JANE STREET GROUP, LLC | 02/14/2025 | 776,800 | $67.75 M | -43.77% | 1.23% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 737,364 | $64.31 M | 19.16% | 1.16% |
NORGES BANK | 02/12/2025 | 711,164 | $62.03 M | 100.00% | 1.12% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 697,027 | $60.80 M | -6.90% | 1.10% |
POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 626,379 | $54.63 M | -28.58% | 0.99% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 604,397 | $52.72 M | 1.20% | 0.95% |
BROWN ADVISORY INC | 02/14/2025 | 578,780 | $50.48 M | -2.52% | 0.91% |
WOODLINE PARTNERS LP | 02/14/2025 | 540,192 | $47.12 M | 19.10% | 0.85% |
CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 490,779 | $42.81 M | 1.85% | 0.77% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 419,190 | $36.56 M | 49.17% | 0.66% |
EMERALD ADVISERS, LLC | 02/11/2025 | 416,866 | $36.36 M | 10.91% | 0.66% |
JANE STREET GROUP, LLC | 02/14/2025 | 408,222 | $35.61 M | 115.83% | 0.64% |
D. E. SHAW & CO., INC. | 02/14/2025 | 361,801 | $31.56 M | 41.50% | 0.57% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 360,208 | $31.42 M | 100.00% | 0.57% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 350,090 | $30.53 M | 26.69% | 0.55% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 338,115 | $29.49 M | 4.16% | 0.53% |
LORD, ABBETT & CO. LLC | 02/14/2025 | 335,043 | $29.22 M | -71.56% | 0.53% |
CASDIN CAPITAL, LLC | 02/14/2025 | 326,378 | $28.47 M | 0.00% | 0.51% |
TWIN TREE MANAGEMENT, LP | 02/10/2025 | 324,600 | $28.31 M | -3.51% | 0.51% |
FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 323,040 | $28.18 M | -3.67% | 0.51% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 303,500 | $26.47 M | 13.88% | 0.48% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 303,432 | $26.47 M | 2.40% | 0.48% |
02/14/2025 | 284,654 | $24.83 M | 100.00% | 0.45% | |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 275,424 | $24.02 M | -15.55% | 0.43% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 275,000 | $23.99 M | -5.17% | 0.43% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 269,990 | $23.55 M | 7.04% | 0.43% |
EMERALD MUTUAL FUND ADVISERS TRUST | 02/14/2025 | 268,978 | $23.46 M | -6.78% | 0.42% |
SQUAREPOINT OPS LLC | 02/14/2025 | 265,420 | $23.15 M | 18.38% | 0.42% |
DEUTSCHE BANK AG\ | 02/14/2025 | 261,363 | $22.80 M | 9.38% | 0.41% |
Blueprint Medicines Corporation institutional Ownership - FAQ's
During the previous two years, 434 institutional investors and hedge funds held shares of Blueprint Medicines Corporation. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 6.87 M
VANGUARD GROUP INC: 6.77 M
PRICE T ROWE ASSOCIATES INC /MD/: 5.68 M
WELLINGTON MANAGEMENT GROUP LLP: 4.28 M
STATE STREET CORP: 2.5 M
FMR LLC: 2.25 M
106.14% of Blueprint Medicines Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 87.67 M shares in the last 24 months. This purchase volume represents approximately $7.85 B in transactions.